These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 36623988)
1. Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy. Ni L; Chen K; Phuong C; Sabbagh AR; Wong AC; Mohamad O; Hsu IC Brachytherapy; 2023; 22(3):304-309. PubMed ID: 36623988 [TBL] [Abstract][Full Text] [Related]
2. A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Yamada Y; Kollmeier MA; Pei X; Kan CC; Cohen GN; Donat SM; Cox BW; Zelefsky MJ Brachytherapy; 2014; 13(2):111-6. PubMed ID: 24373762 [TBL] [Abstract][Full Text] [Related]
3. High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomy. Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Biagioli MC Brachytherapy; 2014; 13(2):123-7. PubMed ID: 24269146 [TBL] [Abstract][Full Text] [Related]
4. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome. Jiang P; van der Horst C; Kimmig B; Zinsser F; Poppe B; Luetzen U; Juenemann KP; Dunst J; Siebert FA Brachytherapy; 2017; 16(1):186-192. PubMed ID: 28341011 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of salvage high-dose rate brachytherapy for prostate-bed recurrences following radical prostatectomy and external beam radiotherapy. Aghili M; Jafari F; Yamrali M; Jaberi R; Cuccia F Int Urol Nephrol; 2022 May; 54(5):1031-1037. PubMed ID: 35239137 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of salvage transurethral high-dose-rate brachytherapy combined with external beam radiation therapy for anastomotic recurrence of prostate cancer after radical prostatectomy: A retrospective analysis. Watanabe K; Kamitani N; Ikeda N; Kawata Y; Tokiya R; Hayashi T; Miyaji Y; Tamada T; Katsui K Brachytherapy; 2024; 23(2):179-187. PubMed ID: 38245406 [TBL] [Abstract][Full Text] [Related]
7. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer. Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027 [TBL] [Abstract][Full Text] [Related]
8. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy. Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236 [TBL] [Abstract][Full Text] [Related]
9. Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity. Rose JN; Crook JM; Pickles T; Keyes M; Morris WJ Brachytherapy; 2015; 14(3):342-9. PubMed ID: 25727178 [TBL] [Abstract][Full Text] [Related]
10. Salvage external beam radiotherapy for locally recurrent prostate cancer after definitive brachytherapy. Rutenberg MS; Meister M; Amin PP; Hussain A; Naslund MJ; Kwok Y Brachytherapy; 2016; 15(6):722-729. PubMed ID: 27693225 [TBL] [Abstract][Full Text] [Related]
11. Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results. Jo Y; Fujii T; Hara R; Yokoyama T; Miyaji Y; Yoden E; Hiratsuka J; Nagai A BJU Int; 2012 Mar; 109(6):835-9. PubMed ID: 21933327 [TBL] [Abstract][Full Text] [Related]
12. Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy. Niehoff P; Loch T; Nürnberg N; Galalae R; Egberts J; Kohr P; Kovács G Brachytherapy; 2005; 4(2):141-5. PubMed ID: 15893268 [TBL] [Abstract][Full Text] [Related]
13. Salvage low-dose-rate brachytherapy for local recurrences after prostatectomy and adjuvant or salvage external beam irradiation: Feasibility study on five patients and literature review. Le Roy C; Gassa F; Rouvière O; Desmettre O; Bringeon G; Charret J; Serre AA; Pommier P Brachytherapy; 2021; 20(1):19-28. PubMed ID: 32798180 [TBL] [Abstract][Full Text] [Related]
14. Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Henríquez I; Sancho G; Hervás A; Guix B; Pera J; Gutierrez C; Abuchaibe O; Martínez-Monge R; Tormo A; Polo A Radiat Oncol; 2014 Apr; 9():102. PubMed ID: 24885287 [TBL] [Abstract][Full Text] [Related]
15. Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation. Baumann BC; Baumann JC; Christodouleas JP; Soffen E Brachytherapy; 2017; 16(2):291-298. PubMed ID: 28139422 [TBL] [Abstract][Full Text] [Related]
16. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929 [TBL] [Abstract][Full Text] [Related]
17. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Valle LF; Lehrer EJ; Markovic D; Elashoff D; Levin-Epstein R; Karnes RJ; Reiter RE; Rettig M; Calais J; Nickols NG; Dess RT; Spratt DE; Steinberg ML; Nguyen PL; Davis BJ; Zaorsky NG; Kishan AU Eur Urol; 2021 Sep; 80(3):280-292. PubMed ID: 33309278 [TBL] [Abstract][Full Text] [Related]
18. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716 [TBL] [Abstract][Full Text] [Related]
19. Salvage prostate HDR brachytherapy combined with interstitial hyperthermia for local recurrence after radiation therapy failure. Kukiełka AM; Hetnał M; Dąbrowski T; Walasek T; Brandys P; Nahajowski D; Kudzia R; Dybek D; Reinfuss M Strahlenther Onkol; 2014 Feb; 190(2):165-70. PubMed ID: 24317192 [TBL] [Abstract][Full Text] [Related]
20. Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes. Devos B; Al Hajj Obeid W; Andrianne C; Diamand R; Peltier A; Everaerts W; Van Poppel H; Van Velthoven R; Joniau S World J Urol; 2019 Aug; 37(8):1507-1515. PubMed ID: 30666400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]